Stephen B. Kennedy

Monrovia, MO 1000, Liberia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications

Five-year immunogenicity and safety follow-up of the PREVAC randomized Trial of Vaccines for Zaire Ebola Virus Disease.

Five-year immunogenicity and safety follow-up of the PREVAC randomized Trial of Vaccines for Zaire Ebola Virus Disease.

Journal: medRxiv : the preprint server for health sciences
Published: June 22, 2026

Comparison of Four Assays That Measure Antibodies to Ebola Virus Glycoprotein.

Comparison of Four Assays That Measure Antibodies to Ebola Virus Glycoprotein.

Journal: bioRxiv : the preprint server for biology
Published: March 27, 2026

Vector-Induced Humoral Responses After rVSVΔG-ZEBOV-GP Immunization Identify Vaccinated Individuals and Correlate With Ebola Virus Glycoprotein Antibodies.

Vector-Induced Humoral Responses After rVSVΔG-ZEBOV-GP Immunization Identify Vaccinated Individuals and Correlate With Ebola Virus Glycoprotein Antibodies.

Journal: The Journal of infectious diseases
Published: August 03, 2024

Diagnostic capacity for fungal keratitis in Africa - Survey in 50 African countries.

Diagnostic capacity for fungal keratitis in Africa - Survey in 50 African countries.

Journal: The ocular surface
Published: August 03, 2023

Randomized Trial of Vaccines for Zaire Ebola Virus Disease.

Randomized Trial of Vaccines for Zaire Ebola Virus Disease.

Journal: The New England journal of medicine
Published: December 14, 2022

Clinical research as a critical component of epidemic response: the case of PREVAIL in Liberia.

Clinical research as a critical component of epidemic response: the case of PREVAIL in Liberia.

Journal: The Lancet. Global health
Published: November 24, 2022

Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory.

Immune response of a two-dose heterologous Ebola vaccine regimen: summary of three African clinical trials using a single validated Filovirus Animal Nonclinical Group enzyme-linked immunosorbent assay in a single accredited laboratory.

Journal: EBioMedicine
Published: September 01, 2022

Poliovirus antibodies following two rounds of campaigns with a type 2 novel oral poliovirus vaccine in Liberia: a clustered, population-based seroprevalence survey.

Poliovirus antibodies following two rounds of campaigns with a type 2 novel oral poliovirus vaccine in Liberia: a clustered, population-based seroprevalence survey.

Journal: The Lancet. Global health
Published: August 02, 2022

Risk Prediction Score for Pediatric Patients with Suspected Ebola Virus Disease.

Risk Prediction Score for Pediatric Patients with Suspected Ebola Virus Disease.

Journal: Emerging infectious diseases
Published: May 24, 2022

Constructing, validating, and updating machine learning models to predict survival in children with Ebola Virus Disease.

Constructing, validating, and updating machine learning models to predict survival in children with Ebola Virus Disease.

Journal: PLoS neglected tropical diseases
Published: February 22, 2022

Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials.

Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials.

Journal: Vaccine
Published: February 03, 2022

Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.

Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries.

Journal: Trials
Published: September 02, 2021
Showing 1-12 of 53

Last Updated: 09/26/2026